

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.00813165 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.46325628 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.41321721 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.34360925 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.31120261 |
| 6 | vocalization behavior (GO:0071625) | 5.05948503 |
| 7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.00326125 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.91271819 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.88403056 |
| 10 | glutamate secretion (GO:0014047) | 4.84670302 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.70116049 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 4.58249141 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.48612901 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.48586861 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.30292673 |
| 16 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.28164568 |
| 17 | neuronal action potential propagation (GO:0019227) | 4.28062395 |
| 18 | exploration behavior (GO:0035640) | 4.26218113 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.23494733 |
| 20 | protein localization to synapse (GO:0035418) | 4.16435892 |
| 21 | regulation of synapse structural plasticity (GO:0051823) | 4.16339958 |
| 22 | synaptic transmission, glutamatergic (GO:0035249) | 4.08275715 |
| 23 | neuron cell-cell adhesion (GO:0007158) | 3.96553350 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.89823757 |
| 25 | neuron-neuron synaptic transmission (GO:0007270) | 3.89631174 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 3.88574022 |
| 27 | layer formation in cerebral cortex (GO:0021819) | 3.76800136 |
| 28 | long-term memory (GO:0007616) | 3.73491531 |
| 29 | proline transport (GO:0015824) | 3.72115487 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.68176519 |
| 31 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64973200 |
| 32 | cellular potassium ion homeostasis (GO:0030007) | 3.55720165 |
| 33 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.52936709 |
| 34 | neurotransmitter transport (GO:0006836) | 3.51992520 |
| 35 | neuron recognition (GO:0008038) | 3.43561285 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.40818303 |
| 37 | positive regulation of membrane potential (GO:0045838) | 3.40220493 |
| 38 | regulation of synaptic plasticity (GO:0048167) | 3.39660495 |
| 39 | regulation of postsynaptic membrane potential (GO:0060078) | 3.39446760 |
| 40 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.36927227 |
| 41 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.35298997 |
| 42 | long-term synaptic potentiation (GO:0060291) | 3.35275010 |
| 43 | dendritic spine morphogenesis (GO:0060997) | 3.34460760 |
| 44 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.31817062 |
| 45 | transmission of nerve impulse (GO:0019226) | 3.30454169 |
| 46 | regulation of neurotransmitter secretion (GO:0046928) | 3.30041456 |
| 47 | regulation of neurotransmitter levels (GO:0001505) | 3.27832079 |
| 48 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.27446775 |
| 49 | regulation of vesicle fusion (GO:0031338) | 3.27423978 |
| 50 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.27317723 |
| 51 | positive regulation of synapse maturation (GO:0090129) | 3.26911739 |
| 52 | synaptic vesicle endocytosis (GO:0048488) | 3.20168265 |
| 53 | sodium ion export (GO:0071436) | 3.19988423 |
| 54 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.15732460 |
| 55 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.12964838 |
| 56 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.12297427 |
| 57 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.11799470 |
| 58 | neuromuscular process controlling posture (GO:0050884) | 3.11684355 |
| 59 | cell communication by electrical coupling (GO:0010644) | 3.10415128 |
| 60 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.09113112 |
| 61 | regulation of neurotransmitter transport (GO:0051588) | 3.06263862 |
| 62 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.06075147 |
| 63 | positive regulation of neurotransmitter transport (GO:0051590) | 3.04875648 |
| 64 | neuronal ion channel clustering (GO:0045161) | 3.02717835 |
| 65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.02175285 |
| 66 | behavioral fear response (GO:0001662) | 3.01463058 |
| 67 | behavioral defense response (GO:0002209) | 3.01463058 |
| 68 | vesicle transport along microtubule (GO:0047496) | 3.01450971 |
| 69 | neuromuscular process controlling balance (GO:0050885) | 3.01189583 |
| 70 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99943273 |
| 71 | striatum development (GO:0021756) | 2.98779351 |
| 72 | membrane depolarization during action potential (GO:0086010) | 2.98096430 |
| 73 | axonal fasciculation (GO:0007413) | 2.97889029 |
| 74 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.97424568 |
| 75 | innervation (GO:0060384) | 2.97021430 |
| 76 | postsynaptic membrane organization (GO:0001941) | 2.96572066 |
| 77 | glycine transport (GO:0015816) | 2.94000451 |
| 78 | detection of calcium ion (GO:0005513) | 2.93940199 |
| 79 | membrane depolarization (GO:0051899) | 2.92715848 |
| 80 | fear response (GO:0042596) | 2.92265491 |
| 81 | prepulse inhibition (GO:0060134) | 2.91933327 |
| 82 | regulation of glutamate secretion (GO:0014048) | 2.90382349 |
| 83 | chemosensory behavior (GO:0007635) | 2.88223593 |
| 84 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.88083073 |
| 85 | positive regulation of synaptic transmission (GO:0050806) | 2.88005649 |
| 86 | learning (GO:0007612) | 2.87326456 |
| 87 | membrane hyperpolarization (GO:0060081) | 2.86518538 |
| 88 | regulation of synaptic transmission (GO:0050804) | 2.86111636 |
| 89 | response to histamine (GO:0034776) | 2.85077696 |
| 90 | auditory behavior (GO:0031223) | 2.84692744 |
| 91 | behavioral response to cocaine (GO:0048148) | 2.84606268 |
| 92 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.83811716 |
| 93 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.83026288 |
| 94 | synaptic transmission (GO:0007268) | 2.82778712 |
| 95 | response to auditory stimulus (GO:0010996) | 2.81537892 |
| 96 | dendrite morphogenesis (GO:0048813) | 2.81299880 |
| 97 | dendritic spine organization (GO:0097061) | 2.80957805 |
| 98 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.79845231 |
| 99 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.79274410 |
| 100 | regulation of ARF protein signal transduction (GO:0032012) | 2.78247318 |
| 101 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.77902725 |
| 102 | cell wall macromolecule catabolic process (GO:0016998) | 2.77842352 |
| 103 | urinary tract smooth muscle contraction (GO:0014848) | 2.66576800 |
| 104 | macroautophagy (GO:0016236) | 2.57450536 |
| 105 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.47500941 |
| 106 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.40398039 |
| 107 | calcium ion-dependent exocytosis (GO:0017156) | 2.35773081 |
| 108 | cell wall macromolecule metabolic process (GO:0044036) | 2.35161564 |
| 109 | behavioral response to ethanol (GO:0048149) | 2.31068459 |
| 110 | cellular response to ATP (GO:0071318) | 2.23136842 |
| 111 | axoneme assembly (GO:0035082) | 2.21874315 |
| 112 | startle response (GO:0001964) | 2.20876769 |
| 113 | central nervous system myelination (GO:0022010) | 2.19656353 |
| 114 | axon ensheathment in central nervous system (GO:0032291) | 2.19656353 |
| 115 | glycosphingolipid biosynthetic process (GO:0006688) | 2.19490047 |
| 116 | presynaptic membrane organization (GO:0097090) | 2.19239426 |
| 117 | adaptation of signaling pathway (GO:0023058) | 2.17814819 |
| 118 | negative regulation of mast cell activation (GO:0033004) | 2.16144736 |
| 119 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.14114185 |
| 120 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.10272984 |
| 121 | alanine transport (GO:0032328) | 2.09330684 |
| 122 | retinal cone cell development (GO:0046549) | 2.04927516 |
| 123 | presynaptic membrane assembly (GO:0097105) | 2.04160675 |
| 124 | serotonin metabolic process (GO:0042428) | 2.03775805 |
| 125 | cyclic nucleotide catabolic process (GO:0009214) | 2.02242819 |
| 126 | sphingoid metabolic process (GO:0046519) | 2.01924060 |
| 127 | smooth muscle tissue development (GO:0048745) | 2.01259013 |
| 128 | cellular potassium ion transport (GO:0071804) | 2.00480989 |
| 129 | potassium ion transmembrane transport (GO:0071805) | 2.00480989 |
| 130 | neuronal action potential (GO:0019228) | 1.99655464 |
| 131 | regulation of clathrin-mediated endocytosis (GO:2000369) | 1.97721888 |
| 132 | nucleobase catabolic process (GO:0046113) | 1.97561504 |
| 133 | regulation of female receptivity (GO:0045924) | 1.97368685 |
| 134 | potassium ion transport (GO:0006813) | 1.93879669 |
| 135 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 1.93277098 |
| 136 | relaxation of cardiac muscle (GO:0055119) | 1.92178699 |
| 137 | growth hormone receptor signaling pathway (GO:0060396) | 1.91974081 |
| 138 | regulation of neurotransmitter uptake (GO:0051580) | 1.91564162 |
| 139 | behavioral response to nicotine (GO:0035095) | 1.91463849 |
| 140 | righting reflex (GO:0060013) | 1.89851987 |
| 141 | primary amino compound metabolic process (GO:1901160) | 1.88221950 |
| 142 | reflex (GO:0060004) | 1.87540851 |
| 143 | Golgi to endosome transport (GO:0006895) | 1.86806726 |
| 144 | cAMP catabolic process (GO:0006198) | 1.86506957 |
| 145 | central nervous system neuron axonogenesis (GO:0021955) | 1.86084830 |
| 146 | photoreceptor cell maintenance (GO:0045494) | 1.84543903 |
| 147 | regulation of acrosome reaction (GO:0060046) | 1.83834530 |
| 148 | inner ear receptor stereocilium organization (GO:0060122) | 1.83493401 |
| 149 | regulation of dendritic spine development (GO:0060998) | 1.83441561 |
| 150 | cardiac conduction (GO:0061337) | 1.82956710 |
| 151 | insulin secretion (GO:0030073) | 1.82193133 |
| 152 | prostate gland growth (GO:0060736) | 1.80261058 |
| 153 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.79597990 |
| 154 | chondroitin sulfate catabolic process (GO:0030207) | 1.79597796 |
| 155 | positive regulation of meiosis (GO:0045836) | 1.79038871 |
| 156 | pyrimidine nucleobase catabolic process (GO:0006208) | 1.77923387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.84241966 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33855316 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.05626410 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02003015 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.91298674 |
| 6 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65388938 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65388938 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.65074090 |
| 9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.63906895 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.60714877 |
| 11 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58282333 |
| 12 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.57517248 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.54335291 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49664912 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.47469239 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.43512465 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35628187 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.23986738 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21929266 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20607002 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.15239251 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10395862 |
| 23 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.96257508 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85122235 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82680277 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81813711 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78631745 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77071667 |
| 29 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.76982430 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70426543 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.69513865 |
| 32 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66312785 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59731487 |
| 34 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.59082908 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58938615 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.56979681 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.55527960 |
| 38 | TP53_16413492_ChIP-PET_HCT116_Human | 1.51150581 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.49841918 |
| 40 | VDR_22108803_ChIP-Seq_LS180_Human | 1.41568379 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39692322 |
| 42 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.37781770 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34727769 |
| 44 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32518574 |
| 45 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32064140 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.30684591 |
| 47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29458600 |
| 48 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29444347 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28881778 |
| 50 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28150059 |
| 51 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.27588517 |
| 52 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.27588517 |
| 53 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27351624 |
| 54 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.27216329 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24966811 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.24299489 |
| 57 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.22494418 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20398642 |
| 59 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20145858 |
| 60 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19552081 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19518063 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.19469678 |
| 63 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18742021 |
| 64 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18742021 |
| 65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17994102 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17913158 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17879938 |
| 68 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.17144227 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16647596 |
| 70 | AR_19668381_ChIP-Seq_PC3_Human | 1.15296449 |
| 71 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15172854 |
| 72 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14695300 |
| 73 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.14209679 |
| 74 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14154682 |
| 75 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.14012180 |
| 76 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13796313 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.12872616 |
| 78 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11311841 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10811407 |
| 80 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10600989 |
| 81 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10306988 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10259650 |
| 83 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10201392 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08191580 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08117404 |
| 86 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06146562 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05571593 |
| 88 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05244793 |
| 89 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.04525770 |
| 90 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04062952 |
| 91 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03556039 |
| 92 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02962056 |
| 93 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02939966 |
| 94 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01123907 |
| 95 | RXR_22108803_ChIP-Seq_LS180_Human | 1.00988957 |
| 96 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00966850 |
| 97 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.00963877 |
| 98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00506452 |
| 99 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99440288 |
| 100 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98688100 |
| 101 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98507897 |
| 102 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98043763 |
| 103 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.97957476 |
| 104 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97704950 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96964037 |
| 106 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96894765 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96739123 |
| 108 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95734026 |
| 109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95554919 |
| 110 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.94985285 |
| 111 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.94985285 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93996645 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.93435975 |
| 114 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92689403 |
| 115 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.92572709 |
| 116 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92003803 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91188614 |
| 118 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91141226 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.89386110 |
| 120 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.88213180 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87869007 |
| 122 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.86494796 |
| 123 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86187510 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86181353 |
| 125 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.85996930 |
| 126 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.85810071 |
| 127 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84464051 |
| 128 | JUN_21703547_ChIP-Seq_K562_Human | 0.82285320 |
| 129 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80328584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.23123441 |
| 2 | MP0003880_abnormal_central_pattern | 4.66869290 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.02903040 |
| 4 | MP0004270_analgesia | 3.59876684 |
| 5 | MP0009745_abnormal_behavioral_response | 3.32973351 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.26639178 |
| 7 | MP0002064_seizures | 3.02401283 |
| 8 | MP0001968_abnormal_touch/_nociception | 2.90890055 |
| 9 | MP0002822_catalepsy | 2.86787119 |
| 10 | MP0009046_muscle_twitch | 2.71869519 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.68640856 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.67318603 |
| 13 | MP0002272_abnormal_nervous_system | 2.57041673 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.49852284 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.48824156 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.48643136 |
| 17 | MP0002736_abnormal_nociception_after | 2.29855673 |
| 18 | MP0001486_abnormal_startle_reflex | 2.24425479 |
| 19 | MP0009780_abnormal_chondrocyte_physiolo | 2.22393401 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.21332110 |
| 21 | MP0002909_abnormal_adrenal_gland | 2.12473491 |
| 22 | MP0005503_abnormal_tendon_morphology | 2.07562830 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.01043807 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.95559594 |
| 25 | MP0001970_abnormal_pain_threshold | 1.93554254 |
| 26 | MP0002733_abnormal_thermal_nociception | 1.92381710 |
| 27 | MP0005646_abnormal_pituitary_gland | 1.91095019 |
| 28 | MP0002067_abnormal_sensory_capabilities | 1.88612120 |
| 29 | MP0003329_amyloid_beta_deposits | 1.87912205 |
| 30 | MP0001984_abnormal_olfaction | 1.77638784 |
| 31 | MP0003195_calcinosis | 1.77557168 |
| 32 | MP0008569_lethality_at_weaning | 1.72672816 |
| 33 | MP0002557_abnormal_social/conspecific_i | 1.69728553 |
| 34 | MP0003787_abnormal_imprinting | 1.69046534 |
| 35 | MP0006276_abnormal_autonomic_nervous | 1.64600227 |
| 36 | MP0002184_abnormal_innervation | 1.63490301 |
| 37 | MP0004811_abnormal_neuron_physiology | 1.62605225 |
| 38 | MP0004858_abnormal_nervous_system | 1.59927424 |
| 39 | MP0001958_emphysema | 1.59009497 |
| 40 | MP0003283_abnormal_digestive_organ | 1.58330412 |
| 41 | MP0004924_abnormal_behavior | 1.55055550 |
| 42 | MP0005386_behavior/neurological_phenoty | 1.55055550 |
| 43 | MP0005645_abnormal_hypothalamus_physiol | 1.54119945 |
| 44 | MP0000955_abnormal_spinal_cord | 1.51620458 |
| 45 | MP0000778_abnormal_nervous_system | 1.47634698 |
| 46 | MP0003879_abnormal_hair_cell | 1.46879346 |
| 47 | MP0004885_abnormal_endolymph | 1.40876734 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.40630265 |
| 49 | MP0003122_maternal_imprinting | 1.40327161 |
| 50 | MP0000427_abnormal_hair_cycle | 1.39318844 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.35782012 |
| 52 | MP0000013_abnormal_adipose_tissue | 1.35158297 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.34872054 |
| 54 | MP0002882_abnormal_neuron_morphology | 1.32908794 |
| 55 | MP0003633_abnormal_nervous_system | 1.31472575 |
| 56 | MP0003045_fibrosis | 1.30583087 |
| 57 | MP0002837_dystrophic_cardiac_calcinosis | 1.29662401 |
| 58 | MP0001502_abnormal_circadian_rhythm | 1.24410978 |
| 59 | MP0005595_abnormal_vascular_smooth | 1.18250130 |
| 60 | MP0004142_abnormal_muscle_tone | 1.15328756 |
| 61 | MP0006054_spinal_hemorrhage | 1.14360811 |
| 62 | MP0002876_abnormal_thyroid_physiology | 1.14228863 |
| 63 | MP0005394_taste/olfaction_phenotype | 1.13267965 |
| 64 | MP0005499_abnormal_olfactory_system | 1.13267965 |
| 65 | MP0005275_abnormal_skin_tensile | 1.12823831 |
| 66 | MP0001542_abnormal_bone_strength | 1.12401830 |
| 67 | MP0001905_abnormal_dopamine_level | 1.11233303 |
| 68 | MP0000383_abnormal_hair_follicle | 1.10287163 |
| 69 | MP0002168_other_aberrant_phenotype | 1.10072790 |
| 70 | MP0005535_abnormal_body_temperature | 1.08840761 |
| 71 | MP0001188_hyperpigmentation | 1.08269446 |
| 72 | MP0003631_nervous_system_phenotype | 1.05991365 |
| 73 | MP0000751_myopathy | 1.04819501 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 1.03542788 |
| 75 | MP0001529_abnormal_vocalization | 1.03369215 |
| 76 | MP0003191_abnormal_cellular_cholesterol | 0.99981928 |
| 77 | MP0008872_abnormal_physiological_respon | 0.99302308 |
| 78 | MP0010678_abnormal_skin_adnexa | 0.97712357 |
| 79 | MP0002069_abnormal_eating/drinking_beha | 0.97277954 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 0.97081385 |
| 81 | MP0002229_neurodegeneration | 0.96740728 |
| 82 | MP0000230_abnormal_systemic_arterial | 0.94288810 |
| 83 | MP0003724_increased_susceptibility_to | 0.94213652 |
| 84 | MP0008874_decreased_physiological_sensi | 0.93734397 |
| 85 | MP0008961_abnormal_basal_metabolism | 0.93508345 |
| 86 | MP0002152_abnormal_brain_morphology | 0.93441319 |
| 87 | MP0004085_abnormal_heartbeat | 0.93178246 |
| 88 | MP0001664_abnormal_digestion | 0.90943760 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.90670060 |
| 90 | MP0003137_abnormal_impulse_conducting | 0.90454238 |
| 91 | MP0004510_myositis | 0.90029597 |
| 92 | MP0004145_abnormal_muscle_electrophysio | 0.89209272 |
| 93 | MP0001177_atelectasis | 0.88703022 |
| 94 | MP0004043_abnormal_pH_regulation | 0.85349718 |
| 95 | MP0001756_abnormal_urination | 0.84898281 |
| 96 | MP0002896_abnormal_bone_mineralization | 0.83190770 |
| 97 | MP0003075_altered_response_to | 0.82735599 |
| 98 | MP0003279_aneurysm | 0.82588962 |
| 99 | MP0005409_darkened_coat_color | 0.81662110 |
| 100 | MP0005551_abnormal_eye_electrophysiolog | 0.80490570 |
| 101 | MP0005508_abnormal_skeleton_morphology | 0.80235177 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.80158645 |
| 103 | MP0002234_abnormal_pharynx_morphology | 0.79863492 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.79622517 |
| 105 | MP0002108_abnormal_muscle_morphology | 0.78720847 |
| 106 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78276525 |
| 107 | MP0003646_muscle_fatigue | 0.78093875 |
| 108 | MP0000604_amyloidosis | 0.77764480 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.77308564 |
| 110 | MP0005164_abnormal_response_to | 0.76102598 |
| 111 | MP0000538_abnormal_urinary_bladder | 0.75753122 |
| 112 | MP0009384_cardiac_valve_regurgitation | 0.75492059 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.75041524 |
| 114 | MP0004742_abnormal_vestibular_system | 0.72061685 |
| 115 | MP0003634_abnormal_glial_cell | 0.71697436 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.71536919 |
| 117 | MP0005187_abnormal_penis_morphology | 0.70308966 |
| 118 | MP0003632_abnormal_nervous_system | 0.70143875 |
| 119 | MP0001963_abnormal_hearing_physiology | 0.69791436 |
| 120 | MP0002693_abnormal_pancreas_physiology | 0.69559181 |
| 121 | MP0003690_abnormal_glial_cell | 0.67770670 |
| 122 | MP0004215_abnormal_myocardial_fiber | 0.67423187 |
| 123 | MP0008004_abnormal_stomach_pH | 0.65381016 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.64815615 |
| 125 | MP0004484_altered_response_of | 0.64701244 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.62748846 |
| 127 | MP0002090_abnormal_vision | 0.61788376 |
| 128 | MP0003183_abnormal_peptide_metabolism | 0.61265278 |
| 129 | MP0001299_abnormal_eye_distance/ | 0.61198526 |
| 130 | MP0001485_abnormal_pinna_reflex | 0.58621507 |
| 131 | MP0000003_abnormal_adipose_tissue | 0.57214495 |
| 132 | MP0000920_abnormal_myelination | 0.56854996 |
| 133 | MP0004130_abnormal_muscle_cell | 0.55613369 |
| 134 | MP0001944_abnormal_pancreas_morphology | 0.55547146 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.53659292 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.53278812 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.82203436 |
| 2 | Myokymia (HP:0002411) | 6.81275555 |
| 3 | Visual hallucinations (HP:0002367) | 5.51643454 |
| 4 | Focal seizures (HP:0007359) | 5.47769282 |
| 5 | Atonic seizures (HP:0010819) | 4.62142656 |
| 6 | Febrile seizures (HP:0002373) | 4.47756575 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.47228651 |
| 8 | Absence seizures (HP:0002121) | 4.18802141 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.78226944 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.77447131 |
| 11 | Dialeptic seizures (HP:0011146) | 3.76611305 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.74872455 |
| 13 | Action tremor (HP:0002345) | 3.68255418 |
| 14 | Hyperventilation (HP:0002883) | 3.45280498 |
| 15 | Ankle clonus (HP:0011448) | 3.42616338 |
| 16 | Depression (HP:0000716) | 3.35695156 |
| 17 | Anxiety (HP:0000739) | 3.35043712 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.17906694 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.17906694 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.17906694 |
| 21 | Papilledema (HP:0001085) | 3.13422829 |
| 22 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.12583160 |
| 23 | Amblyopia (HP:0000646) | 3.08959608 |
| 24 | Poor eye contact (HP:0000817) | 3.08129630 |
| 25 | Broad-based gait (HP:0002136) | 3.01759042 |
| 26 | Thyroid-stimulating hormone excess (HP:0002925) | 2.93779850 |
| 27 | Impaired social interactions (HP:0000735) | 2.89247379 |
| 28 | Abnormal social behavior (HP:0012433) | 2.89247379 |
| 29 | Progressive inability to walk (HP:0002505) | 2.88064137 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.84586768 |
| 31 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.84586768 |
| 32 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.84586768 |
| 33 | Truncal ataxia (HP:0002078) | 2.79859245 |
| 34 | Dysmetria (HP:0001310) | 2.78252625 |
| 35 | Abnormal eating behavior (HP:0100738) | 2.72320946 |
| 36 | Dysdiadochokinesis (HP:0002075) | 2.70489084 |
| 37 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.70345471 |
| 38 | Gaze-evoked nystagmus (HP:0000640) | 2.67606257 |
| 39 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.66836468 |
| 40 | Postural instability (HP:0002172) | 2.65339682 |
| 41 | Torticollis (HP:0000473) | 2.64907472 |
| 42 | Mucopolysacchariduria (HP:0008155) | 2.64027088 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.64027088 |
| 44 | Epileptiform EEG discharges (HP:0011182) | 2.59568592 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.58692329 |
| 46 | Ventricular fibrillation (HP:0001663) | 2.58446559 |
| 47 | Pheochromocytoma (HP:0002666) | 2.56919443 |
| 48 | EEG with generalized epileptiform discharges (HP:0011198) | 2.51216510 |
| 49 | Agitation (HP:0000713) | 2.50404101 |
| 50 | Hematochezia (HP:0002573) | 2.50266179 |
| 51 | Mutism (HP:0002300) | 2.48828738 |
| 52 | Focal dystonia (HP:0004373) | 2.47034314 |
| 53 | Increased corneal curvature (HP:0100692) | 2.45656598 |
| 54 | Keratoconus (HP:0000563) | 2.45656598 |
| 55 | Bradykinesia (HP:0002067) | 2.44192845 |
| 56 | Neurofibrillary tangles (HP:0002185) | 2.41735604 |
| 57 | Drooling (HP:0002307) | 2.40413740 |
| 58 | Excessive salivation (HP:0003781) | 2.40413740 |
| 59 | Dysostosis multiplex (HP:0000943) | 2.40318297 |
| 60 | Urinary urgency (HP:0000012) | 2.40129125 |
| 61 | Hypsarrhythmia (HP:0002521) | 2.39397941 |
| 62 | Increased cerebral lipofuscin (HP:0011813) | 2.36759099 |
| 63 | Hemiparesis (HP:0001269) | 2.35088547 |
| 64 | Impaired smooth pursuit (HP:0007772) | 2.32591812 |
| 65 | Widely spaced teeth (HP:0000687) | 2.29689767 |
| 66 | Craniofacial dystonia (HP:0012179) | 2.26329147 |
| 67 | Spastic gait (HP:0002064) | 2.25735210 |
| 68 | True hermaphroditism (HP:0010459) | 2.23578440 |
| 69 | Chronic hepatic failure (HP:0100626) | 2.23393984 |
| 70 | Termporal pattern (HP:0011008) | 2.21366121 |
| 71 | Insidious onset (HP:0003587) | 2.21366121 |
| 72 | Limb dystonia (HP:0002451) | 2.21097690 |
| 73 | Megalencephaly (HP:0001355) | 2.20633509 |
| 74 | Clumsiness (HP:0002312) | 2.20287252 |
| 75 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19691973 |
| 76 | Hypoventilation (HP:0002791) | 2.19669282 |
| 77 | Annular pancreas (HP:0001734) | 2.19034720 |
| 78 | Abnormality of the lower motor neuron (HP:0002366) | 2.18211330 |
| 79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.17983811 |
| 80 | Pancreatic fibrosis (HP:0100732) | 2.17662259 |
| 81 | Stereotypic behavior (HP:0000733) | 2.17564312 |
| 82 | Diplopia (HP:0000651) | 2.17495493 |
| 83 | Abnormality of binocular vision (HP:0011514) | 2.17495493 |
| 84 | Abnormality of the corticospinal tract (HP:0002492) | 2.17256076 |
| 85 | Failure to thrive in infancy (HP:0001531) | 2.15572266 |
| 86 | Ankyloglossia (HP:0010296) | 2.14985602 |
| 87 | Intention tremor (HP:0002080) | 2.14824174 |
| 88 | Status epilepticus (HP:0002133) | 2.13278825 |
| 89 | Insomnia (HP:0100785) | 2.13121235 |
| 90 | Hemiplegia (HP:0002301) | 2.12828843 |
| 91 | Syncope (HP:0001279) | 2.12648538 |
| 92 | Neuroendocrine neoplasm (HP:0100634) | 2.11734925 |
| 93 | Abnormal drinking behavior (HP:0030082) | 2.11498734 |
| 94 | Polydipsia (HP:0001959) | 2.11498734 |
| 95 | Scanning speech (HP:0002168) | 2.10413128 |
| 96 | Decreased circulating renin level (HP:0003351) | 2.07730711 |
| 97 | Broad metatarsal (HP:0001783) | 2.07634075 |
| 98 | Pancreatic cysts (HP:0001737) | 2.07457381 |
| 99 | Abnormality of the renal medulla (HP:0100957) | 2.06667917 |
| 100 | Bundle branch block (HP:0011710) | 2.04618003 |
| 101 | Psychosis (HP:0000709) | 2.04024345 |
| 102 | Nephronophthisis (HP:0000090) | 2.03907197 |
| 103 | Generalized hypopigmentation of hair (HP:0011358) | 2.01792025 |
| 104 | Nuclear cataract (HP:0100018) | 2.00962928 |
| 105 | Hypoplastic ischia (HP:0003175) | 1.99309144 |
| 106 | Inability to walk (HP:0002540) | 1.98057881 |
| 107 | Lower limb muscle weakness (HP:0007340) | 1.97797669 |
| 108 | Absent speech (HP:0001344) | 1.97386936 |
| 109 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.96563654 |
| 110 | Type II lissencephaly (HP:0007260) | 1.95686794 |
| 111 | Retinal dysplasia (HP:0007973) | 1.94754455 |
| 112 | Hypoplasia of the odontoid process (HP:0003311) | 1.93947889 |
| 113 | Impaired vibratory sensation (HP:0002495) | 1.93587293 |
| 114 | Congenital stationary night blindness (HP:0007642) | 1.92393730 |
| 115 | Blue irides (HP:0000635) | 1.92168968 |
| 116 | Cardiovascular calcification (HP:0011915) | 1.92151701 |
| 117 | Choroideremia (HP:0001139) | 1.92014323 |
| 118 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.90611735 |
| 119 | Congenital sensorineural hearing impairment (HP:0008527) | 1.90423782 |
| 120 | Disproportionate short-trunk short stature (HP:0003521) | 1.90183516 |
| 121 | Bradycardia (HP:0001662) | 1.90018978 |
| 122 | Genetic anticipation (HP:0003743) | 1.89885987 |
| 123 | Clonus (HP:0002169) | 1.89668366 |
| 124 | Vascular tortuosity (HP:0004948) | 1.89001376 |
| 125 | Amelogenesis imperfecta (HP:0000705) | 1.88601717 |
| 126 | Vacuolated lymphocytes (HP:0001922) | 1.87554023 |
| 127 | Aortic dissection (HP:0002647) | 1.87523139 |
| 128 | Generalized myoclonic seizures (HP:0002123) | 1.86271640 |
| 129 | Protruding tongue (HP:0010808) | 1.85956343 |
| 130 | Rapidly progressive (HP:0003678) | 1.84935983 |
| 131 | Abnormal EKG (HP:0003115) | 1.84880586 |
| 132 | Delusions (HP:0000746) | 1.84740608 |
| 133 | Hypercortisolism (HP:0001578) | 1.84727191 |
| 134 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.83687017 |
| 135 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.83687017 |
| 136 | Vascular calcification (HP:0004934) | 1.81822045 |
| 137 | Arterial tortuosity (HP:0005116) | 1.81791786 |
| 138 | Polyphagia (HP:0002591) | 1.81461552 |
| 139 | Prolonged QT interval (HP:0001657) | 1.80594708 |
| 140 | Fetal akinesia sequence (HP:0001989) | 1.79979336 |
| 141 | Gait ataxia (HP:0002066) | 1.78805190 |
| 142 | Abnormality of the ischium (HP:0003174) | 1.78596208 |
| 143 | Incomplete penetrance (HP:0003829) | 1.77937687 |
| 144 | Medial flaring of the eyebrow (HP:0010747) | 1.77603952 |
| 145 | Impaired pain sensation (HP:0007328) | 1.77163284 |
| 146 | Abnormality of pain sensation (HP:0010832) | 1.77163284 |
| 147 | Rigidity (HP:0002063) | 1.76690828 |
| 148 | Cystic liver disease (HP:0006706) | 1.75858119 |
| 149 | Obstructive sleep apnea (HP:0002870) | 1.75548416 |
| 150 | Tubulointerstitial nephritis (HP:0001970) | 1.75032200 |
| 151 | Large for gestational age (HP:0001520) | 1.72265027 |
| 152 | Buphthalmos (HP:0000557) | 1.71625402 |
| 153 | Abnormality of midbrain morphology (HP:0002418) | 1.71004388 |
| 154 | Molar tooth sign on MRI (HP:0002419) | 1.71004388 |
| 155 | Gait imbalance (HP:0002141) | 1.70903026 |
| 156 | Hypothermia (HP:0002045) | 1.67276607 |
| 157 | Fair hair (HP:0002286) | 1.66247861 |
| 158 | Mitral stenosis (HP:0001718) | 1.66032746 |
| 159 | Tubular atrophy (HP:0000092) | 1.64505615 |
| 160 | Amyloidosis (HP:0011034) | 1.64428311 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.25644652 |
| 2 | NTRK3 | 4.54634268 |
| 3 | EPHA4 | 4.11139408 |
| 4 | MAP3K9 | 3.48963748 |
| 5 | MAP3K4 | 2.85956753 |
| 6 | MINK1 | 2.69266081 |
| 7 | MAP2K7 | 2.55160731 |
| 8 | MAP3K12 | 2.49268645 |
| 9 | DAPK2 | 2.41868606 |
| 10 | ADRBK2 | 2.33772912 |
| 11 | MARK1 | 2.33320468 |
| 12 | RIPK4 | 2.20014629 |
| 13 | KSR2 | 2.17663882 |
| 14 | CAMKK1 | 2.15729689 |
| 15 | MAP2K4 | 2.11794308 |
| 16 | PAK6 | 2.01224633 |
| 17 | PRKD3 | 1.99547550 |
| 18 | WNK3 | 1.95960989 |
| 19 | NTRK1 | 1.94949173 |
| 20 | NTRK2 | 1.67754735 |
| 21 | TRPM7 | 1.64096626 |
| 22 | MAP3K2 | 1.60289677 |
| 23 | STK39 | 1.58246572 |
| 24 | DAPK1 | 1.57817349 |
| 25 | CDK5 | 1.56692146 |
| 26 | CASK | 1.54841032 |
| 27 | MAPKAPK3 | 1.50910680 |
| 28 | GRK5 | 1.50539813 |
| 29 | PRKD2 | 1.40448813 |
| 30 | CDK19 | 1.38749831 |
| 31 | ARAF | 1.36354541 |
| 32 | CAMKK2 | 1.34718322 |
| 33 | PNCK | 1.32219006 |
| 34 | PLK2 | 1.26408276 |
| 35 | UHMK1 | 1.25512935 |
| 36 | NME1 | 1.23350984 |
| 37 | KSR1 | 1.23299318 |
| 38 | GRK1 | 1.21979436 |
| 39 | STK38 | 1.21612987 |
| 40 | LMTK2 | 1.15459125 |
| 41 | SIK2 | 1.15247023 |
| 42 | PRKCG | 1.11183978 |
| 43 | MAP4K2 | 1.11100428 |
| 44 | RET | 1.08498168 |
| 45 | MAP3K13 | 1.08290972 |
| 46 | FES | 1.05243892 |
| 47 | MYLK | 1.03625466 |
| 48 | PRPF4B | 1.03447767 |
| 49 | MAPK13 | 1.03313572 |
| 50 | RIPK1 | 1.03158934 |
| 51 | PHKG2 | 1.02583851 |
| 52 | PHKG1 | 1.02583851 |
| 53 | CAMK2A | 1.02059801 |
| 54 | CAMK1 | 0.97988232 |
| 55 | BMPR2 | 0.97631181 |
| 56 | PINK1 | 0.97592161 |
| 57 | MAP3K1 | 0.96382866 |
| 58 | TNIK | 0.95060863 |
| 59 | BMPR1B | 0.91358424 |
| 60 | LIMK1 | 0.90525499 |
| 61 | PRKCH | 0.89845352 |
| 62 | ADRBK1 | 0.88741336 |
| 63 | FGFR2 | 0.88388406 |
| 64 | PKN1 | 0.86499212 |
| 65 | SGK223 | 0.86411348 |
| 66 | SGK494 | 0.86411348 |
| 67 | CAMK2B | 0.85318986 |
| 68 | TYRO3 | 0.84715500 |
| 69 | TAOK1 | 0.84357709 |
| 70 | PAK3 | 0.84238878 |
| 71 | TNK2 | 0.84008530 |
| 72 | PTK2B | 0.81923681 |
| 73 | EPHA3 | 0.81013728 |
| 74 | PIK3CA | 0.79318160 |
| 75 | LATS1 | 0.79082160 |
| 76 | OXSR1 | 0.78211413 |
| 77 | STK11 | 0.77537307 |
| 78 | DYRK1A | 0.74874257 |
| 79 | SCYL2 | 0.74645611 |
| 80 | ROCK1 | 0.72418264 |
| 81 | LATS2 | 0.70313576 |
| 82 | SGK2 | 0.70056826 |
| 83 | EPHB1 | 0.69941688 |
| 84 | MAPK7 | 0.69491136 |
| 85 | CDK18 | 0.68574267 |
| 86 | PDPK1 | 0.68317262 |
| 87 | CDK15 | 0.67990366 |
| 88 | SGK3 | 0.66671077 |
| 89 | CDK14 | 0.66635269 |
| 90 | IRAK1 | 0.66276682 |
| 91 | RAF1 | 0.65456094 |
| 92 | STK38L | 0.65445983 |
| 93 | SGK1 | 0.64606516 |
| 94 | DDR2 | 0.64415642 |
| 95 | MAPK12 | 0.64230672 |
| 96 | PDK1 | 0.64077676 |
| 97 | AKT3 | 0.63709084 |
| 98 | FER | 0.63613896 |
| 99 | RPS6KA2 | 0.62948402 |
| 100 | PRKCE | 0.62428079 |
| 101 | MAP2K1 | 0.60793026 |
| 102 | TGFBR2 | 0.60628582 |
| 103 | INSRR | 0.59447602 |
| 104 | CAMK1D | 0.59237694 |
| 105 | MARK2 | 0.58943385 |
| 106 | CDK11A | 0.58458906 |
| 107 | CAMK2D | 0.57981830 |
| 108 | NUAK1 | 0.56747346 |
| 109 | MAP3K6 | 0.55693108 |
| 110 | MAP3K7 | 0.54864328 |
| 111 | ERBB2 | 0.52388688 |
| 112 | CAMK1G | 0.51928066 |
| 113 | PRKAA2 | 0.51614743 |
| 114 | PRKD1 | 0.50240199 |
| 115 | CHUK | 0.49456364 |
| 116 | MAP3K3 | 0.49189934 |
| 117 | CSNK1G2 | 0.48785666 |
| 118 | PDGFRB | 0.48605534 |
| 119 | PTK2 | 0.48148956 |
| 120 | CAMK2G | 0.47222211 |
| 121 | SIK3 | 0.47032178 |
| 122 | MAPKAPK5 | 0.46860162 |
| 123 | GRK7 | 0.46827261 |
| 124 | PRKCZ | 0.46400349 |
| 125 | CDC42BPA | 0.46242672 |
| 126 | RPS6KA3 | 0.45122073 |
| 127 | PRKAA1 | 0.43698572 |
| 128 | ALK | 0.42722919 |
| 129 | ABL1 | 0.42689333 |
| 130 | JAK1 | 0.41583790 |
| 131 | WNK4 | 0.41494871 |
| 132 | EPHB2 | 0.41316584 |
| 133 | WNK1 | 0.40407313 |
| 134 | FYN | 0.40401385 |
| 135 | TRIB3 | 0.40329680 |
| 136 | PDGFRA | 0.38272092 |
| 137 | DMPK | 0.38175792 |
| 138 | MAPK10 | 0.37925722 |
| 139 | FGR | 0.35066020 |
| 140 | MUSK | 0.34670494 |
| 141 | MAP2K6 | 0.33991123 |
| 142 | ROCK2 | 0.33829779 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.39403029 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21945051 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.63970783 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.61726242 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.59573480 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.58309848 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.56593494 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.42363330 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.40785792 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.38890263 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.26128203 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 2.20435743 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.13899631 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 2.10570786 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.87083165 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83540493 |
| 17 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.82299787 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.79258680 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.77889050 |
| 20 | Renin secretion_Homo sapiens_hsa04924 | 1.72165578 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.67723916 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.64549878 |
| 23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59404787 |
| 24 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.58513055 |
| 25 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.56677133 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55390007 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.52524106 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.51997890 |
| 29 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38161999 |
| 30 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.37050553 |
| 31 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.34531694 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.30748624 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.28233541 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.28054041 |
| 35 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26497903 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26079615 |
| 37 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.25938172 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.21680789 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.19831074 |
| 40 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17881725 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17404441 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16134042 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12128586 |
| 44 | Glioma_Homo sapiens_hsa05214 | 1.08114043 |
| 45 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.05966704 |
| 46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03683773 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.00182987 |
| 48 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.99994990 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97877311 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 0.96843581 |
| 51 | Melanogenesis_Homo sapiens_hsa04916 | 0.94588702 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90730043 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90321660 |
| 54 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89767636 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89507783 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.88759594 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.87579406 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86514842 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.82747801 |
| 60 | Axon guidance_Homo sapiens_hsa04360 | 0.80993215 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80562880 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.79861535 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76592453 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74386107 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.73215513 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.73097400 |
| 67 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.71838221 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71810591 |
| 69 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69110721 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.68844150 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.68097636 |
| 72 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.67410121 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65296224 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.65170495 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.64206313 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63167710 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62970515 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62480231 |
| 79 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.62398266 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62073283 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61071954 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.60656872 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60634443 |
| 84 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60229036 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.59924959 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.59513950 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58386852 |
| 88 | Amoebiasis_Homo sapiens_hsa05146 | 0.55673383 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55577020 |
| 90 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54081176 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.52615256 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51667787 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51594821 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.50886038 |
| 95 | Insulin resistance_Homo sapiens_hsa04931 | 0.50498927 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.50132003 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.48509233 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47554264 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47351880 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47249568 |
| 101 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47079694 |
| 102 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46884716 |
| 103 | Alzheimers disease_Homo sapiens_hsa05010 | 0.46872029 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45986277 |
| 105 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45633349 |
| 106 | Platelet activation_Homo sapiens_hsa04611 | 0.45361828 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45181093 |
| 108 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44045576 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.43987170 |
| 110 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43956729 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43808937 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.43457201 |
| 113 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43057565 |
| 114 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.42777934 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41771812 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.40811472 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40724372 |
| 118 | Endometrial cancer_Homo sapiens_hsa05213 | 0.39649351 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37221303 |
| 120 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.35507785 |
| 121 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.35277787 |
| 122 | Endocytosis_Homo sapiens_hsa04144 | 0.35094811 |
| 123 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33173928 |
| 124 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32373726 |
| 125 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.31833178 |
| 126 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.29302290 |
| 127 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29292561 |
| 128 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.27955042 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.26991257 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26618440 |

